[1]
McKeown, J.
: By Notice of Motion the applicants, Pfizer Canada Inc. and Pfizer Corporation ("Pfizer") applied for an order requiring the respondent the Minister of National Health and Welfare ("Minister") to forward the New Drug Submissions ("NDS") of the respondent, Nu-Pharm Inc. ("Nu-Pharm") relating to 50, 100 and 200 mg fluconazole tablets ("Nu-Pharm NDS") to Pfizer.